The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway

The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway

Due to the increasing incidence of malignant gliomas, particularly glioblastoma multiforme (GBM), a simple and reliable GBM diagnosis is needed to screen early the death-threaten patients. This study aimed to identify a protein that can be used to discriminate GBM from low-grade astrocytoma and eluc...

Full description

Bibliographic Details
Main Authors: Chih-Wei Chen, Cheng-Han Yang, Yuan-Ho Lin, Ya-Chin Hou, Tain-Junn Cheng, Sheng-Tsung Chang, Yu-Hua Huang, Shang-Ting Chung, Chung-Ching Chio, Yan-Shen Shan, Hung-Chi Cheng, Wen-Tsan Chang
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:International Journal of Molecular Sciences
Subjects:
glioma
glioblastoma multiforme (GBM)
tumor recurrence
tumor metastasis
epithelial-mesenchymal transition (EMT)
fibronectin (FN)
Online Access:https://www.mdpi.com/1422-0067/22/7/3782

Internet

https://www.mdpi.com/1422-0067/22/7/3782

Similar Items